Inventor · disambiguated record
Sharon Shechter
Also filed as: SHECHTER SHARON
38 granted patents·12 pending applications·570 citations·filing 2011–2023
98Inventor score
Files withKARYOPHARM THERAPEUTICS INC28GALECTIN SCIENCES LLC7BIOGEN MA INC6STINGTHERA INC4SANDANAYAKA VINCENT P3
Top patents by PatentIndex Score
50 records- 0198US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0297US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0397US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0497US10335393B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·20 cites·12 claims
- 0597US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 0697US10058535B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Aug 28, 2018·24 cites·1 claims
- 0797US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 0897US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 0997US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1097US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1197US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1297US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1397US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1496US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1596US9079865B2Hydrazide containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Jul 14, 2015·38 cites·13 claims
- 1695US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 1795US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 1894US10722497B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2019·Granted Jul 28, 2020·3 cites·26 claims
- 1994US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 2093US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 2193US9550757B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·24 cites·25 claims
- 2292US10617677B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2018·Granted Apr 14, 2020·3 cites·18 claims
- 2392US9428490B2Nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Aug 30, 2016·27 cites·8 claims
- 2492US9303000B2Olefin containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Apr 5, 2016·28 cites·10 claims
- 2592US8513230B2Nuclear transport modulators and uses thereofSHACHAM SHARON·Filed 2011·Granted Aug 20, 2013·39 cites·7 claims
- 2688US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2787US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 2887US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 2986US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 3085US10925859B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2020·Granted Feb 23, 2021·1 cites·21 claims
- 3183US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3282US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3378US11583530B2Compounds for the prevention and treatment of medical disorders and uses thereofGALECTIN SCIENCES LLC·Filed 2018·Granted Feb 21, 2023·1 cites·29 claims
- 3478US11318120B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2021·Granted May 3, 2022·0 cites·6 claims
- 3574US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 3672US12377102B2Compounds for the prevention and treatment of medical disorders and uses thereofGALECTIN SCIENCES LLC·Filed 2022·Granted Aug 5, 2025·0 cites·3 claims
- 3772US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3865US2023127345A1Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereofGALECTIN SCIENCES LLC·Filed 2022·Application pending·0 cites
- 3963US2020087313A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4062US11576924B2Compounds for the prevention and treatment of diseases and the use thereofGALECTIN SCIENCES LLC·Filed 2018·Granted Feb 14, 2023·0 cites·4 claims
- 4161US2023132265A1Compounds for the prevention and treatment of diseases and the use thereofGALECTIN SCIENCES LLC·Filed 2022·Application pending·0 cites
- 4257US2017137430A1Nuclear Transport Modulators And Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4350US2023113570A1Oxoacridinyl acetic acid derivatives and methods of useSTINGTHERA INC·Filed 2022·Application pending·0 cites
- 4447US10745358B2Oxoacridinyl acetic acid derivatives and methods of useSILICON SWAT INC·Filed 2018·Granted Aug 18, 2020·0 cites·3 claims
- 4542US2016016916A1Exo Olefin-Containing Nuclear Transport Modulators and Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4641US2019367552A1Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereofGALECTIN SCIENCES LLC·Filed 2017·Application pending·0 cites
- 4738US2020061095A1Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use ThereofGALECTIN SCIENCES LLC·Filed 2018·Application pending·0 cites
- 4835US2022227761A1Oxoacridinyl acetic acid derivatives and methods of useSTINGTHERA INC·Filed 2020·Application pending·0 cites
- 4934US11414387B2Oxoacridinyl acetic acid derivatives and methods of useSTINGTHERA INC·Filed 2020·Granted Aug 16, 2022·0 cites·23 claims
- 5034US2022251079A1Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of useSTINGTHERA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sharon Shechter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →